The effect of three different oral doses of verapamil on the disposition of theophylline

@article{Stringer2005TheEO,
  title={The effect of three different oral doses of verapamil on the disposition of theophylline},
  author={K. Stringer and J. Mallet and M. Clarke and J. Lindenfeld},
  journal={European Journal of Clinical Pharmacology},
  year={2005},
  volume={43},
  pages={35-38}
}
SummaryResults of previous studies suggest that the theophylline-verapamil drug interaction may be dependent on verapamil dose. Therefore, in a randomized four-way cross over study, 12 healthy males received theophylline, as a single intravenous dose of aminophylline, alone (phase I) and after a four day regimen of oral verapamil 40 mg (phase II), 80 mg (phase III), and 120 mg (phase IV) every 8 h. Serial blood samples were collected over a 24 hour period for determination of serum theophylline… Expand
Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models
TLDR
Results revealed that verapamil enhanced the bioavailability of sitagliptin probably by inhibiting its absorption via P-gp and/or the CYP3A4mediated biotransformation in rats. Expand
Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats
TLDR
Hesperetin and naringenin co-administration significantly enhanced the area under the curve (AUC), maximum plasma concentration (Cmax) and elimination half life (t1/2) of rasagiline with a concomitant reduction in clearance (CL/F) in both SDS and MDS. Expand
Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations
TLDR
Assessment of victim and perpetrator risks of drug transporters and cytochrome P450 enzymes is featured, utilizing empirical and mechanistic approaches combined with clinical data and physiologically based pharmacokinetic modeling approaches to facilitate bespoke risk assessment in target patient populations. Expand
Influence of nifedipine, nitrendipine and verapamil at low concentration on antipyrine metabolism examined by extracorporeal rat liver perfusion.
TLDR
The present experiment suggests that low concentrations of CCI can exert hepatoprotective effect, however, confirmation of this conclusion requires further studies using other experimental methods. Expand
Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
TLDR
Analysis of published systemic clearance and volume of distribution at steady state (Vss) values taken from over 200 clinical studies shows that in some cases the twofold criteria method is an unreasonable expectation when the observed data are obtained from studies with small sample size. Expand
A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
TLDR
The PBPK model can predict the disposition of CYP1A2, 2D6, and 3A drugs during pregnancy and suggests that the magnitude of hepatic CYP2D6 induction during T3 ranges from 100 to 200%. Expand
Pharmacokinetic drug-drug interactions in the intensive care unit - single-centre experience and literature review.
TLDR
DDIs as well as their side-effects are challenging regarding their precise evaluation, especially due to the need for multidrug treatment in critically ill patients, so concentration-controlled therapy should be recommended, especially for treatment with vancomycin, digoxin and valproate. Expand
A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data
Background and ObjectivesCurrent cytochrome P450 (CYP) 1A2 and 3A4 ontogeny profiles, which are derived mainly from in vitro studies and incorporated in paediatric physiologically basedExpand
A Mechanistic Approach for the Scaling of Clearance in Children
TLDR
Paediatric clinical trial development could greatly benefit from clearance scaling, particularly in guiding dosing regimens, since the proportion of clearance via different elimination pathways is age-dependent and information could be gained on the developmental extent of drug-drug interactions. Expand
Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
TLDR
This study suggests that the developed paediatric PBPK model can be used to scale pharmacokinetics from adults, and accurate prediction of pharmacokinetic parameters in children will aid in the development of dosing regimens and sampling times, thus increasing the efficiency of paediatric clinical trials. Expand
...
1
2
...

References

SHOWING 1-10 OF 17 REFERENCES
The Effect of Verapamil on the Pharmacokinetic Disposition of Theophylline in Cigarette Smokers
TLDR
The area under the curve (AUC0‐∞) and volume of distribution at steady‐state (Vss) for theophylline were not statistically different between the two study phases, and the relevance of a potential theophyLLine‐verapamil drug interaction remains unclear. Expand
Effect of calcium channel blockers on theophylline disposition
TLDR
The modest reduction in theophylline clearance observed after verapamil and diltiazem is not likely to produce clinically significant increases in thephylline concentrations in most patients. Expand
Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
TLDR
Antipyrine and theophylline disposition was studied in healthy volunteer subjects in the control state while the subjects were taking verapamil orally four times daily or diltiazem orally three times daily, resulting in prolonged antipyrine half-life with no change in distribution volume. Expand
Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline.
TLDR
Verapamil and nifedipine at usual clinical doses are unlikely to cause clinically significant changes in theophylline disposition. Expand
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy
TLDR
Drug interactions with other liver‐metabolized drugs may occur during therapy with these calcium antagonists and nifedipine appears to increase liver blood flow whereas diltiazem inhibits oxidative drug metabolism. Expand
Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.
  • K. Renton
  • Chemistry, Medicine
  • Biochemical pharmacology
  • 1985
TLDR
Results suggest that diltiazem and verapamil may have the potential to cause drug interactions involving inhibition of drug biotransformation, as both drugs could prolong pentobarbital-induced sleeping times in mice at doses comparable to those used in man. Expand
Calcium Antagonists in the Management of Asthma: Breakthrough or Ballyhoo?
TLDR
Data has been generated on the effects of verapamil, diltiazem, nifedipine, and several investigational agents on experimentally induced asthma, indicating that none of these agents significantly affects resting bronchomotor tone, and their efficacy in preventing bronchospasm is a function of the drug, dose, route of administration and method of bronchoprovocation. Expand
Calcium-channel blocking agents for gastrointestinal disorders.
TLDR
There is no experimental evidence of a major antisecretory effect of calcium-channel blocking drugs in therapy of gastrointestinal disease, but nifedipine has been shown to have a greater effect than placebo in improving symptoms in patients with achalasia, and diltiazem has been suggested as potential therapy in Patients with chest pain secondary to excessive esophageal contraction. Expand
Calcium and stimulus-secretion coupling in gastric fundic mucosa. Effect of inhibition of calcium transport by verapamil on gastric acid secretion in the isolated guinea pig fundic mucosa and in healthy subjects.
TLDR
It is concluded that one of the mechanisms by which extracellular calcium concentration influences acid secretion is by transmembrane influx of Ca2+ during stimulation. Expand
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
Raynaud's phenomenon may cause severe digital pain and functional disability, particularly in patients with underlying connective-tissue disease. The treatment of this condition is difficult.1 Nife...
...
1
2
...